Articles amb requisits d'accés públic - Kai WucherpfennigMés informació
TotalNIHHHMIDoDDFGNSFMelanoma Research AllianceSusan G. KomenCIHRA*StarEuropean CommissionSNSFEMBLV Foundation, USAHFSPDOENHMRCFRQSNSERCNSFCWellcomeDamon Runyon Cancer Research FoundationCZIGatesFWFFWOBanking Foundation "la Caixa"NWOCancer Research UKNIHRRCNANRGovernment of SpainSCLGovernment of ItalyJDRFAlex's Lemonade StandAmerican Brain Tumor Association
No estan disponibles en cap lloc: 4
Cytotoxic T cells in PD-L1–positive malignant pleural mesotheliomas are counterbalanced by distinct immunosuppressive factors
MM Awad, RE Jones, H Liu, PH Lizotte, EV Ivanova, M Kulkarni, ...
Cancer immunology research 4 (12), 1038-1048, 2016
Requisits: Damon Runyon Cancer Research Foundation
Targeting of the CD161 inhibitory receptor enhances T-cell–mediated immunity against hematological malignancies
F Alvarez Calderon, BH Kang, O Kyrysyuk, S Zheng, H Wang, ...
Blood 143 (12), 1124-1138, 2024
Requisits: US National Institutes of Health
Studying dynamic plasma membrane binding of TCR-CD3 chains during immunological synapse formation using donor-quenching FRET and FLIM-FRET
E Gagnon, A Connolly, J Dobbins, KW Wucherpfennig
The Immune Synapse: Methods and Protocols, 259-289, 2017
Requisits: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
Injectable Oxygen Microparticles Boost Radiation–Mediated In Situ Vaccination and Systemic Antitumor Immune Responses
R Patenaude, S Yasmin-Karim, Y Peng, KW Wucherpfennig, W Ngwa, ...
International Journal of Radiation Oncology* Biology* Physics 116 (4), 906-915, 2023
Requisits: US National Science Foundation
Disponibles en algun lloc: 111
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
P Jiang, S Gu, D Pan, J Fu, A Sahu, X Hu, Z Li, N Traugh, X Bu, B Li, J Liu, ...
Nature medicine 24 (10), 1550-1558, 2018
Requisits: US National Institutes of Health
An immunogenic personal neoantigen vaccine for patients with melanoma
PA Ott, Z Hu, DB Keskin, SA Shukla, J Sun, DJ Bozym, W Zhang, A Luoma, ...
Nature 547 (7662), 217-221, 2017
Requisits: US National Institutes of Health
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
DB Keskin, AJ Anandappa, J Sun, I Tirosh, ND Mathewson, S Li, ...
Nature 565 (7738), 234-239, 2019
Requisits: US National Institutes of Health, Howard Hughes Medical Institute
A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade
L Jerby-Arnon, P Shah, MS Cuoco, C Rodman, MJ Su, JC Melms, ...
Cell 175 (4), 984-997. e24, 2018
Requisits: US National Institutes of Health, Howard Hughes Medical Institute
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation
T Korn, J Reddy, W Gao, E Bettelli, A Awasthi, TR Petersen, BT Bäckström, ...
Nature medicine 13 (4), 423-431, 2007
Requisits: German Research Foundation
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
SC Formenti, NP Rudqvist, E Golden, B Cooper, E Wennerberg, ...
Nature medicine 24 (12), 1845-1851, 2018
Requisits: US Department of Defense, US National Institutes of Health
A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
D Pan, A Kobayashi, P Jiang, L Ferrari de Andrade, RE Tay, AM Luoma, ...
Science 359 (6377), 770-775, 2018
Requisits: US National Institutes of Health, A*Star, Singapore
MHC-II neoantigens shape tumour immunity and response to immunotherapy
E Alspach, DM Lussier, AP Miceli, I Kizhvatov, M DuPage, AM Luoma, ...
Nature 574 (7780), 696-701, 2019
Requisits: US National Institutes of Health, Howard Hughes Medical Institute
Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq
MG Filbin, I Tirosh, V Hovestadt, MKL Shaw, LE Escalante, ...
Science 360 (6386), 331-335, 2018
Requisits: US National Institutes of Health, Howard Hughes Medical Institute, European …
Deconstructing the peptide-MHC specificity of T cell recognition
ME Birnbaum, JL Mendoza, DK Sethi, S Dong, J Glanville, J Dobbins, ...
Cell 157 (5), 1073-1087, 2014
Requisits: US National Institutes of Health, Howard Hughes Medical Institute
Regulation of T cell receptor activation by dynamic membrane binding of the CD3ɛ cytoplasmic tyrosine-based motif
C Xu, E Gagnon, ME Call, JR Schnell, CD Schwieters, CV Carman, ...
Cell 135 (4), 702-713, 2008
Requisits: US National Institutes of Health, Canadian Institutes of Health Research
Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation
A Peters, LA Pitcher, JM Sullivan, M Mitsdoerffer, SE Acton, B Franz, ...
Immunity 35 (6), 986-996, 2011
Requisits: US National Institutes of Health
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity
L Ferrari de Andrade, RE Tay, D Pan, AM Luoma, Y Ito, S Badrinath, ...
Science 359 (6383), 1537-1542, 2018
Requisits: US Department of Defense, US National Institutes of Health, A*Star, Singapore
Polarized release of T-cell-receptor-enriched microvesicles at the immunological synapse
K Choudhuri, J Llodrá, EW Roth, J Tsai, S Gordo, KW Wucherpfennig, ...
Nature 507 (7490), 118-123, 2014
Requisits: US National Institutes of Health, Wellcome Trust
Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma
Z Hu, DE Leet, RL Allesøe, G Oliveira, S Li, AM Luoma, J Liu, J Forman, ...
Nature medicine 27 (3), 515-525, 2021
Requisits: US National Science Foundation, US National Institutes of Health, Howard …
Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma
T Hara, R Chanoch-Myers, ND Mathewson, C Myskiw, L Atta, L Bussema, ...
Cancer cell 39 (6), 779-792. e11, 2021
Requisits: US National Institutes of Health, Howard Hughes Medical Institute, Human …
Les dades de publicació i de finançament es determinen automàticament per mitjà d'un programa informàtic